The novel therapy of the medication represents a major breakthrough in the management of type 2 diabetes. Different to existing drugs, tirzepatide impacts two pathways – GLP-1 and the GIP hormone – resulting in https://tirzepatide-peptide688176.ambien-blog.com/48909358/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment